Home » Topics » Dermatologic, BioWorld Science

Dermatologic, BioWorld Science
RSS

Connetics to develop clobetasol mousse for dermatoses

Jan. 16, 1998

Genzyme General discontinues U.S. development of Sepracoat

Jan. 15, 1998

New class of glucocorticoids with an improved pharmacological profile

Jan. 15, 1998

IMPDH inhibitor VX-497 advances to clinical trials

Jan. 14, 1998

OrthoLogic makes equity investment in Chrysalis; acquires rights to new peptide

Jan. 13, 1998

Cellegy acquires Anogesic

Jan. 13, 1998

ADCON-L submitted to regulatory authorities

Jan. 9, 1998

ABX-IL-8 slated to enter clinical testing

Jan. 8, 1998

NDA filed for betamethasone mousse

Jan. 7, 1998

Biomatrix's Hyalform approved in additional markets; PMA resubmission planned in U.S.

Jan. 5, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 6, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Regulatory actions for May 5, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied...